MBL2 and systemic lupus erythematosus: Present study revealed significantly altered levels of lectin pathway PRMs (including ficolin-2, MBL, MASP-1, MASP-3, and MAp44), as well as increased levels of their corresponding autoantibodies in SLE patients compared to HCs.